TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitrolife Sweden AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,500,716
|
1,288,259
|
1,059,462 |
| Financial expenses |
11,358
|
36
|
109 |
| Earnings before taxes |
466,940
|
427,348
|
332,217 |
| EBITDA |
514,052
|
428,337
|
345,477 |
| Total assets |
1,204,930
|
938,915
|
722,060 |
| Current assets |
1,036,591
|
672,285
|
447,056 |
| Current liabilities |
105,195
|
104,039
|
104,669 |
| Equity capital |
1,076,161
|
805,045
|
590,598 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
168
|
164
|
163 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
89.3%
|
85.7%
|
81.8% |
| Turnover per employee |
8,933
|
7,855
|
6,500 |
| Profit as a percentage of turnover |
31.1%
|
33.2%
|
31.4% |
| Return on assets (ROA) |
39.7%
|
45.5%
|
46.0% |
| Current ratio |
985.4%
|
646.2%
|
427.1% |
| Return on equity (ROE) |
43.4%
|
53.1%
|
56.3% |
| Change turnover |
212,457
|
228,797
|
234,464 |
| Change turnover % |
16%
|
22%
|
28% |
| Chg. No. of employees |
4
|
1
|
7 |
| Chg. No. of employees % |
2%
|
1%
|
4% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.